Lian indicated the oral VK2735 program is expected to advance into Phase III for obesity, with initiation targeted for the third quarter of 2026. "We currently expect to initiate this program in the ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2025 Earnings Call Transcript February 11, 2026 Viking Therapeutics, Inc. misses ...
The Environmental Protection Agency says it is ending credits to automakers who install automatic start-stop ignition systems ...
A study reported that the conventional method of searching follicular fluid didn’t find all the eggs. The new technology ...
Learn how to implement OpenID Connect (OIDC) for enterprise SSO. Technical guide for engineering leaders on identity providers, scopes, and secure integration.
In my previous post, I walked through how disconnected MCP servers and AI agents create a growing blind spot in enterprise ...